Lv1
2 积分 2023-04-21 加入
Molecular and Clinical Characteristics of Patients with Non–Small Cell Lung Cancer Harboring KRAS G12V Mutations
17天前
已完结
Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications
28天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
28天前
已完结
Advancing therapeutics in small-cell lung cancer
1个月前
已完结
Small cell lung cancer transformation: From pathogenesis to treatment
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) – biology, clinical results and future directions
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
1个月前
已完结
皖公网安备34019202002308
